November 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
Capitol Perspectives
CEO Corner
Companies To Watch
From Policy to Execution
Industry Research
Inside The Industry
- The Power That Industry Lexicon Has To Support Change
- Life Sciences Dealmaking In The Time Of COVID-19
- The Road To Commercialization: Small Company Considerations
- Pets, Perseverance, and Manufacturing Facility Bring Biotech Success
- Paragraph IV Patent Challenges During COVID-19: What’s Next?
Leadership Lessons
Ask The Board
- What Was Your Biggest Business Learning From The First Half Of 2020 And Why?
- What Is Your Biggest Concern Regarding Biopharma’s Reputation With The American People If We Do Not Have A COVID-19 Vaccine By The End Of 2020?
- What — If Any — “Silver Linings” Have You Observed Take Place At Your Company Resulting From The Chaos Caused By COVID-19?
This website uses cookies to ensure you get the best experience on our website. Learn more